Mixing Covishield, Covaxin shows better immunogenicity: ICMR study

A study by Indian Council of Medical Research involving 98 people, 18 of whom had inadvertently received Covishield as first dose and Covaxin as the second in Uttar Pradesh, showed that combining......

Ramdev's Patanjali claims to have COVID-19 medicine; Govt frowns

Yoga guru Ramdev's herbal medicine company Patanjali Ayurved on Tuesday claimed to have discovered a medicine that could cure coronavirus in just seven days -- a claim that the Ayush Ministry......

Experts welcome WHO's decision to resume HCQ clinical trial

Terming World Health Organisation's decision to resume testing of hydroxychloroquine as a potential treatment for COVID-19 in its global clinical trial "a step in the right direction", experts said......

COVID-19: The threat from people with no symptoms

'Testing is a very good strategy if only symptomatic people are transmitting the disease.''Here asymptomatic people, with minimum, trivial symptoms, are transmitting too.''Testing, treating,......

Abhijit Banerjee and the mystique of the Nobel Prize

Does Abhijit Banerjee's Nobel Prize help India reduce extreme poverty, asks Rajeev Srinivasan. IMAGE: Professor Abhijit Vinayak Banerjee won the 2019 Nobel Prize in Economics. Photograph: Brian......

Banerjee-Duflo duo and Bandhan Bank's anti-poverty scheme

According to a 2011 impact assessment study of the programme by Banerjee and Duflo, along with economists Raghabendra Chattopadhyay and Jeremy Shapiro, Bandhan’s THP results in a 15 per cent......

How Banerjee-Duflo's economic theory is relevant for India

For Duflo and Banerjee, an important part of their work has been ensuring that the agency of the “beneficiaries” -- usually, in developing countries like India, poorer individuals -- is......

The mouse that bit Microsoft

A long time ago when Bill Gates was not yet the world's richest man and Microsoft hadn't yet become the giant that it is today, the man and his company had very different views on the patenting of......